Previous Article | Next Article 
Journal of Virology, September 1999, p. 7421-7429, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Point Mutations in the Avian Sarcoma/Leukosis Virus
3' Untranslated Region Result in a Packaging Defect
Jonathan M.
Aschoff,
Douglas
Foster,
and
John M.
Coffin*
Department of Molecular Biology and
Microbiology, Tufts University School of Medicine, Boston,
Massachusetts 02111
Received 27 January 1999/Accepted 25 May 1999
 |
ABSTRACT |
The 3' untranslated region (3' UTR) between the 3' end of
env and the long terminal repeat is well conserved among
avian retroviruses and is essential for efficient replication. Deletion
of the dr1 element within the 3' UTR has been reported to have various
effects, including reduced levels of unspliced RNA in the cytoplasm,
decreased stability of unspliced RNA, decreased particle production,
and decreased genomic RNA packaging. To probe the role of specific sequences within dr1 in virus replication, site-directed mutagenesis was utilized to perturb parts of the predicted secondary structure of
dr1. Seven of thirteen mutations had no significant effect; the others
resulted in an approximately 10- to 20-fold reduction in replication.
These mutants were further characterized and found to impair
cytoplasmic accumulation of unspliced RNA only slightly. Furthermore,
no decreases were observed in the stability of the unspliced RNA or in
the production of virus particles. Genomic RNA packaging, however, was
reduced by about 10-fold. Similar amounts of particles were produced by
cells containing the mutant and wild-type DNA, and all particles
contained similar levels of reverse transcriptase activity. The results
suggest that the region of the dr1 disrupted by the mutations plays a
role in genomic RNA packaging, although that packaging may not be the
only role for dr1.
 |
INTRODUCTION |
The 3' untranslated region (3' UTR)
between the 3' end of env and the long terminal repeat (LTR)
is well conserved among avian retroviruses and is essential for
efficient replication. By contrast to the region in ancestral avian
leukosis virus (ALV) strains, the RNA of Rous sarcoma virus (RSV)
contains two copies of the 3' UTR, which flank the oncogene
src (Fig. 1A) (32).
Within one copy of the 3' UTR lie two sequences referred to as direct repeat 1 (dr1) and dr2 separated in the 3' copy by a unique sequence (30). This repetition was probably created as part of the
recombination events that led to the acquisition of src by
the virus (31). The duplicated regions have subsequently
diverged somewhat in sequence, although they both managed to retain
function, since either copy will support efficient replication of RSV
(17, 22, 24).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
ALV provirus. Shown is the viral insert in pJON5WT, a
proviral clone of a replication-competent ASLV in pBluescript SK( ).
The 3' UTR of pJON5WT was created by deletion from Prague-RSV-C of nt
7097 to 8992, which removed src and most of the sequence
between src and the 3' LTR. The riboprobe used in RNase
protection assays to differentiate unspliced from spliced RNA is
depicted by the solid bar. The riboprobe corresponds to nt 53 to 532 of Prague-RSV-C, spanning the splice junction at nt 398. The riboprobe
used to distinguish subgroup B from B/E RNA is shown as a thick broken
line and corresponds to nt 5515 to 5961 of Prague-RSV-B. The straight
line depicts the regions derived from Prague-RSV-C or Prague-RSV-B.
Thin dotted lines indicate the vector sequences.
|
|
All retroviruses must maintain the proper balance of spliced and
unspliced RNA in the cytoplasm. In the case of simple retroviruses, the
one species of spliced RNA serves as template for the translation of
the Env proteins. The unspliced RNA serves as template for the
translation of Gag and Gag-Pol precursor proteins and also serves as genomic RNA for packaging into progeny virions. Exactly how
avian type C retroviruses export their unspliced RNA from the nucleus
to the cytoplasm remains unresolved. Complex retroviruses such as human
immunodeficiency virus (HIV) and human T-cell leukemia virus (HTLV)
export their unspliced and partially spliced RNA from the nucleus in a
manner that has been well characterized (5, 6, 10, 23). The
HIV Rev (HTLV Rex) protein, translated from a fully spliced RNA,
shuttles in and out of the nucleus (20), where it
multimerizes on an RNA element named RRE (RxRE in HTLV) (18, 19,
27), located near the middle of env and therefore found only in RNA that has not been fully spliced (4). Rev is then able to expose its nuclear export signal, thereby facilitating the export of the bound RNA (11).
Analogous to the Rev/RRE system, simian type D retroviruses contain a
nuclear export activity within their 3' UTR (3, 33). The 3'
UTRs of Mason-Pfizer monkey virus (3) and simian
retroviruses types 1 and 2 (33) function to promote the
nuclear export of unspliced viral RNA from the nucleus to the
cytoplasm. The sequences within the 3' UTRs of these retroviruses
responsible for this property were named "constitutive transport
elements" (CTEs) (3) and are able to functionally replace
the Rev/RRE system of HIV type 1 (HIV-1) (3, 26, 33).
The findings with type D viruses prompted Ogert et al. (17)
to investigate the role in nuclear export of sequences within the 3'
UTR of RSV, since the region had already been shown to be required for
efficient viral replication (24). These authors, using an
RSV construct bearing a dr1 deletion (17) or a dr1 containing point mutations (16), showed that the 3' UTR
facilitated the accumulation of unspliced RNA in the cytoplasm.
However, unlike the case for simian type D retroviruses, no nuclear
retention of unspliced RNA occurred with avian retrovirus constructs
lacking a dr1 element (17). The 3' UTR of RSV functions to
some degree in RNA stability, since two different dr1 deletion mutants
make unspliced RNA that is degraded about twice as rapidly as is the wild type (17, 22).
Another RSV construct lacking dr1 elements but retaining src
was shown to be defective in particle production, even though transcription and translation were relatively intact (22).
Genomic RNA expressed from this construct was slightly less abundant in the cytoplasm compared to the wild type and was not retained in the
nucleus (22). Furthermore, all three viral RNA species
displayed an approximately twofold reduction in stability
(22). A third ALV construct lacking a dr1 was shown to be
defective in packaging its genomic RNA (24). Particle
production was slightly impaired, but it paralleled the cytoplasmic
level of mutant RNA, which failed to package (24).
Because of the conflicting results of several experiments with deletion
constructs, we decided instead to probe the role of specific sequences
within the dr1 and have therefore introduced 13 different single or
tandem substitution mutations into the dr1 of an avian sarcoma/leukosis
virus (ASLV) proviral construct. The present study describes 6 of those
13 mutations, each of which reduced viral replication by at least
10-fold. These mutations had little effect on the cytoplasmic
accumulation of unspliced RNA or RNA stability, but they reduced
packaging of viral genomic RNA by an amount comparable to the reduction
in replication displayed by each of the mutants.
 |
MATERIALS AND METHODS |
Plasmids.
pJON5 plasmids contained a nonpermuted copy of an
ASLV provirus in pBluescript (Fig. 1). First, a PCR fragment was
generated from the pATV8 clone of Prague-RSV-C (13), adding
a ClaI site immediately upstream of the 5' LTR and ending at
the PstI site at nucleotide (nt) 263. Nucleotide numbering
is based on the sequenced genome of the pATV8 (21). The
downstream primer also introduced a point mutation into the
SacI site at nt 255. The upstream primer contained the
sequence 5'-CCATCGATAATGTAGTCTTATGCAATACTCCTGTAG-3' and the
downstream primer contained the sequence
5'-CCCTGCAGTAAAGCTCCCTC-3'. pJON1 was made by ligation of
this PCR fragment into pBluescript at the ClaI and
PstI sites. pJON2 was created by ligation of a PstI fragment (nt 263 to 1542) from NTRE-4B (28,
29) into pJON1. pJON4 was made by cutting pJON2 with
AatII (nt 1250) and SacI and then ligating in
place of the excised fragment (nt 1250 to 6865) the corresponding
fragment from NTRE-4B (subgroup B/E env) (28,
29). pJON5 was created by exchanging the
KpnI-SacI (nt 4995 to 6865) fragment of pJON4
with the same fragment from transformation-defective Prague-RSV-B, thus
resulting in a subgroup B env gene which rendered progeny
virus from the clone unable to reinfect the QT6/BD cells used in the
transfection experiments. Eliminating reinfection allowed for better
comparison of mutant to wild-type expression. The constructs were
completed by cleaving pJON5 with SacI and ligating in a
SacI fragment (nt 6865 to 255) from Prague-RSV-C to provide
the 3' UTR and the 3' LTR. These fragments contained either a wild-type
or mutant 3' UTR. This SacI fragment lacked src
and the downstream copy of the dr1 (deletion of nt 7097 to 8992).
A plasmid was constructed to serve as a template for riboprobes and
consisted of an EcoRI-BamHI (nt
53 to 532)
viral fragment, which spans the RSV splice donor (nt 398) to
differentiate between unspliced and spliced species, cloned into
pBluescript (Fig. 1). The subgroup B derived env probe was
constructed by inserting into pBSSK
, a PCR fragment containing nt
5515 to 5961 of the ALV env sequence. pMyc23, a plasmid
serving as a transfection control and pMyc23 donor, a plasmid serving
as a template for its riboprobe, were obtained from K. Beemon
(14). pMyc23 contains the cellular myc gene
cloned into pGEM2. pMyc23 Donor contains a
NotI-BstXI fragment which is the exonic portion
around the myc 5' splice site cloned into pGEM2.
Cell culture and DNA transfection.
QT6 cells are a cell line
derived from a chemically induced fibrosarcoma of Japanese quail
(15). QT6 cells were grown in modified Richter's medium
containing 5% fetal calf serum (FCS). DF1 cells are immortalized
chicken fibroblasts (12) and were grown in modified
Richter's medium containing 10% FCS. All transfections were done with
Lipofectamine (Gibco-BRL) according to the manufacturer's recommendations. Briefly, each 100-mm culture dish of 40% confluent cells was transfected with 10 µg of plasmid DNA for 16 h in 4 ml
of OptiMEM (Gibco-BRL) medium containing 40 µl of Lipofectamine and
2.5% FCS for QT6 cells, or 5% FCS for DF1 cells. After transfection, 4 ml of modified Richter's medium was added to the cultures. The medium contained 7.5% FCS for QT6 cells or 15% FCS for DF1 cells. The
transfection efficiency was controlled by cotransfecting pMyc23 with
the pJON5 plasmids. QT6 cells were harvested at 40 h, at which
point medium and cells were analyzed to determine viral protein and RNA
levels. DF1 cells were passaged twice weekly for 8 weeks, and reverse
transcriptase (RT) assays were performed on the culture medium before
each cell passage.
In experiments measuring viral RNA stability, 2 µg of actinomycin D
(Gibco-BRL) per ml was added at 40 h (time zero) in fresh modified
Richter's medium with 5% FCS, and QT6 cells were harvested at 0, 6, 12, and 24 h for analysis of the viral RNA levels.
RT assays.
Production of virus was assayed by determining
the amount of RT activity in the culture medium. One milliliter of
culture medium was filtered through a 0.45-µm (pore-size) filter, and the virus was pelleted and incubated with 20 µl of assay buffer (50 mM Tris-Cl [pH 7.5], 60 mM NaCl, 10 mM MgCl2, 20 mM
dithiothreitol, 10 mM dTTP, 5 mg of oligo(dT) per ml, 10 mg of poly(rA)
per ml, 0.05% Nonidet P-40 NP-40, 0.2 µCi of
[35S]dTTP) at 37°C for 1 h. The reaction was
stopped by the addition of 200 µl of stop solution (0.1%
Na4P2O7, 15 mM NaCl, 0.1 mg of bovine serum albumin per ml), and products were precipitated by the
addition of 25 µl of 60% trichloroacetic acid (TCA). After incubation on ice for 5 min, the cocktail was filtered through nitrocellulose filters and washed three times with 6% TCA, and the
filters were dried and counted in a scintillation counter.
RNA isolation, cell fractionation, and RNase protection
assays.
Total cellular RNA, nuclear RNA, cytoplasmic RNA, and
viral RNA were isolated by using the RNeasy Kit (Qiagen) according to the manufacturer's recommendations. The exact formulation of Qiagen buffers RLT, RW1, and RPE is proprietary, so only approximate formulations are provided. Briefly, cellular fractionation was achieved
by treating the cells with buffer RLN (50 mM Tris-Cl [pH 8.0], 140 mM
NaCl, 1.5 mM MgCl2, 0.5% Nonidet P-40) for 5 min on ice,
followed by centrifugation at 400 × g for 3 min at 4°C. Then, 1 ml of supernatant was used as the cytoplasmic fraction, and the pellet was washed again in RLN and used as the nuclear fraction. Cells, cell nucleus preparations, or viruses were pelleted and then disrupted with 3.8 ml of buffer RLT (ca. 4 M guanidinium thiocyanate, 10 mM Tris-Cl [pH 8.0], 1 mM EDTA) supplemented with 1%
2-mercaptoethanol. Then, 3.8 ml of 70% ethanol (or 2.8 ml of absolute
ethanol for the 1-ml sample of cytoplasmic RNA) was added. Genomic DNA
in the total cell and cell nucleus samples was sheared by 12 passes through a syringe with an 18-gauge needle. The mixtures were
then added to the RNA-binding silica spin column and centrifuged at
14,000 × g for 1 min. The column was washed once with
7 ml of buffer RW1 (ca. 4 M guanidinium thiocyanate, 10 mM Tris-Cl [pH
8.0], 1 mM EDTA), and two times with 5 ml of buffer RPE (ca. 10 mM Tris-Cl [pH 8.0], 1 mM EDTA, 80% ethanol). RNA was then eluted in
200 µl of water, treated with DNase I, and repurified by using
the RNeasy Kit prior to A260/280 determination.
The virion RNA was too dilute to determine an accurate
A260/280 measurement. Instead, virus was simply
pelleted from identical volumes of culture medium from each
transfection condition. Pelleting was done by ultracentrifugation with
an SW41 rotor at 35,000 rpm for 1 h at 4°C. RNA was extracted
from the virus pellets with the RNeasy kit, and the entire sample was
used in the RNase protection assay.
RNase protection assays were performed on all RNA preparations and
utilized [32P]rUTP-labeled antisense riboprobes generated
with the Riboprobe Systems Kit (Promega) according to the
manufacturer's recommendations. The probe was synthesized at a low
specific activity such that, according to the Poisson distribution,
less than 2% of the probe molecules contained more than 1 [32P]rUTP. This step greatly reduced the
background coming from the decay of probes that were still radioactive,
since radioactive decay causes degradation of the probe. Then, 10 to 20 µg of cellular RNA, or the entire sample of virion-associated RNA,
was hybridized to probe (400,000 cpm/sample) for 16 h at 50°C,
followed by treatment with the RNases A (5 µg/ml) and T1 (10 U/ml)
for 1 h at room temperature. Samples were then extracted with
phenol-chloroform, ethanol precipitated, resuspended in 95%
formamide buffer, and loaded onto a 5% polyacrylamide gel containing 8 M urea. Electrophoresis was carried out for 1 h at constant power
(80 W) in 1× TBE buffer (90 mM Tris-Cl, 90 mM boric acid, 2 mM EDTA).
Gels were dried onto Whatman paper and then placed against a detection
screen used in conjunction with the Storm PhosphorImager (Molecular
Dynamics). Bands were quantitated by using Imagequant (Molecular
Dynamics) software.
Protein isolation and immunoblots.
Total cellular protein
was isolated by sonicating cell pellets resuspended in
phosphate-buffered saline plus pepstatin A (1 µg/ml), leupeptin (1.37 µg/ml), phenylmethylsulfonyl fluoride (100 µg/ml), and
dithiothreitol (0.5 mM). The sonicate was cleared by centrifugation at
14,000 × g for 10 min and then concentrated through a
microconcentrator (Amicon) with an exclusion size of 30 kDa. The
concentration of the sample was determined by biuret assay, and 30 µg
of total cell protein was mixed 1:1 (vol/vol) with 2× sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer
(4% SDS, 20% glycerol, 120 mM Tris-Cl [pH 6.8], 0.01% bromophenol
blue) and subjected to SDS-10% PAGE. Virus pellets were directly
resuspended in 1× SDS-PAGE loading buffer and subjected to SDS-15%
PAGE. Gels were transferred to nitrocellulose and blocked with 5% dry
milk in TBS-T (25 mM Tris base, 3 mM KCl, 140 mM NaCl, 0.1% Tween-20
[pH 8.0]) for 1 h. On cellular protein blots, Pr76 Gag protein
was detected by using a 1:1,000 dilution of affinity-purified rabbit
anti-CA-NC antibodies, a gift of V. Vogt. On virus protein blots, p27
CA protein was detected by using a 1:1,000 dilution of rabbit anti-CA
antiserum, a gift of V. Vogt. All blots were then washed in TBS-T. All
blots were incubated next with a 1:30,000 dilution of an alkaline
phosphatase-conjugated anti-rabbit secondary monoclonal antibody,
washed three more times (5 min each time) in TBS-T, and then incubated
with a fluorescent substrate for 2 min (both from the ECF Western
blotting kit [Amersham]). All primary and secondary antisera were
added to TBS-T containing 1% dry milk, and incubations were for 1 h at room temperature. Fluorescence was quantitated on the Storm
fluorescence imager, which read blue fluorescence, and Imagequant
software was used for data manipulation. Band intensities were in the
linear range of the Storm imager as determined by standard curves.
 |
RESULTS |
Selection of mutants.
Thirteen ASLV clones, containing
mutations in their 3' UTR, were constructed by site-directed
mutagenesis (Fig. 2). The rationale for
making 11 of the mutations (M2, M3, M3B, M4, M4A, M4B, M4C, M4D, M5,
M6, and M7) was to reduce the number of unpaired bases observed in a
putative secondary structure which had been predicted by using M-fold
software (Fig. 2B) (34). ML2 was intended to be a
compensatory exchange of sequences from one side of a loop to the
other. M3A was intended to maintain the structure but alter the
sequence. The logic was to test whether maintenance of the secondary
structure was critical for function and was of greater importance than
sequence. As indicated in Fig. 2, seven of the mutations, intended to
alter structure, replicated at wild-type levels with little or no delay
in replication kinetics (data not shown). Therefore, it seems possible
that specific sequences, rather than secondary structure, could play a
larger role in the function of the dr1. We decided to further
characterize the six mutants that failed to attain wild-type levels of
replication, regardless of their effect on putative secondary
structure.


View larger version (43K):
[in this window]
[in a new window]
|
FIG. 2.
Site-directed mutations in the upstream copy of dr1. The
six substitution mutations shown in boldface in panel A and circled in
panel B (M3, M3A, M3B, M4, M5, and ML2) resulted in at least a 10-fold
reduction in viral replication compared to the wild type (Fig. 3). The
remaining seven dr1 mutants failed to cause a permanent reduction in
viral replication. (A) Aligned sequences of the upstream copy of dr1
from Pr-RSV-C nt 6897 to 6989 and the mutations studied here. Dashes
indicate sequence identity. (B) Predicted secondary structure of dr1.
The structure was predicted by using M-fold (34). The
approximate locations of the mutations are indicated.
|
|
Some point mutations in the 3' UTR of ASLV reduce viral
replication.
The substitution mutations selected reduced
replication by 10-fold for at least 2 months of culture (Fig.
3). Replication was assayed by measuring
the production of RT activity by DF1 cells transfected with each mutant
provirus. All mutants displayed similarly slow increases in RT
activity, eventually reaching 5 to 10% that of the wild-type virus
(Fig. 3). The mutants were able to maintain this level of virus
production throughout the experiment, and reversion of mutant sequences
as assayed by sequencing RT-PCR-amplified fragments of virion RNA was
not observed (data not shown). Almost identical results were observed
when the mutant and wild-type DNAs containing a subgroup B/E
env in place of the subgroup B env were
transfected into QT6 cells (data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of substitution mutations in dr1 on ASLV
replication. The results of RT assays performed on culture medium of
DF1 cells transfected with 10 µg of the indicated DNAs per ml are
shown. Cells were passed when confluent (twice weekly). Samples were
taken immediately before passing. Error bars indicate the standard
deviation of values obtained from three separate transfections with the
same DNA. The large variability in the RT activity levels of the
mutants may have resulted from systemic errors in the assay, given the
consistency of RT activity fluctuations among the mutants.
|
|
Point mutations in the 3' UTR of ASLV reduce cytoplasmic
accumulation of unspliced RNA only slightly.
To avoid difficulties
caused by multiple rounds of infection, all of the experiments
described hereafter utilized transient transfection of QT6 cells with
plasmids encoding subgroup B virus. This protocol allowed for a better
comparison of mutant to wild-type virus, since all viral RNA came
directly from the transfected DNA and not from reinfection, which could
have been occurring at different rates for each mutant tested. All
studies utilizing QT6 cells were completed without passaging the cell cultures.
We first examined the effects of the mutations on the synthesis,
splicing, and transport of spliced and unspliced viral RNA from the
nucleus to the cytoplasm. In experiments with RSV constructs lacking
dr1 sequences, reduced levels of unspliced viral RNA in the cytoplasm
have been observed (17, 22). Cytoplasmic levels of spliced
env RNA, however, are unaffected by the complete deletion of
dr1 sequences (17, 22). To test whether the point mutations had an effect similar to that of the removal of dr1 sequences entirely,
QT6 cells were transfected with the mutant or wild-type ASLV constructs
and tested for expression 40 h later. As a control for
transfection and for cellular fractionation, pMyc23 was cotransfected with the retroviral constructs, and its expression was measured in the
same hybridization reaction as the viral RNA, but with a different
specific riboprobe. The results of two representative RNase protection
assays are shown in Fig. 4. None of the
point mutations had a noticeable effect on overall RNA levels. The
effect of the mutations on the ratio of unspliced to spliced RNA and their relative amounts in nuclear and cytoplasmic fractions are given
in Table 1. Even though there was less
unspliced viral RNA in the cytoplasm for any one mutant as compared to
the wild type, all mutants also displayed a lower level of unspliced
RNA in the total RNA sample. Therefore, ratios of unspliced/spliced RNA
in the cytoplasm were compared to ratios of unspliced/spliced RNA in
the total RNA sample to generate a second set of ratios which more
accurately described the effects of the mutations on the cytoplasmic
accumulation of unspliced RNA (Table 1). The differences in nuclear
export of unspliced RNA between any individual mutant and the wild type
(Table 1) were relatively small, up to about two-fold for M5, and
cannot account for the reduction in replication shown by the RT assay
(Fig. 3).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of dr1 mutations on cytoplasmic accumulation of
unspliced viral RNA. QT6 cells were transfected with 10 µg of the
mutant DNAs in a subgroup B background to prevent reinfection. A total
of 10 µg of plasmid pMyc23 was included as a transfection control.
RNase protection assays were performed by using total, nuclear, and
cytoplasmic RNA preparations isolated 40 h after transfection with
the radiolabeled riboprobe shown in Fig. 1, as well as a riboprobe
specific for myc. (A) Schematic diagram of riboprobe and
protected RNA species. The thin dashed line indicates vector sequences.
The sizes of the riboprobe and the protected fragments are indicated.
(B) RNase protection of fractionated cellular RNA. The asterisks
indicate bands that arise from protection of the probe by both ends of
the same RNA molecule or by two ends from two different RNA
molecules.
|
|
Nuclear ratios of unspliced/spliced RNA displayed the least variability
among the constructs. It is notable that there was no concomitant
nuclear retention of unspliced viral RNA to explain its reduction in
the cytoplasm. This result is in agreement with the results of
experiments with the dr1 deletion constructs (17, 22). The
results with ASLV constructs are in stark contrast to the results of
similar experiments with type D retroviruses, where there is an obvious
nuclear retention of the unspliced RNA accounting for its absence from
the cytoplasm when the 3' UTR is mutated (3, 9, 33). It is
therefore difficult to ascribe the effects of these mutations to
nuclear export rather than to cytoplasmic accumulation of unspliced RNA.
The dr1 point mutations did not affect the stability of the
unspliced viral RNA.
It has been reported previously that RSV
proviral constructs lacking dr1 sequences express unspliced RNA which
is less stable in the cytoplasm than wild-type unspliced RNA (17,
22). Since nuclear retention of unspliced RNA could not account
for the reduced levels of unspliced RNA in the cytoplasm of QT6 cells
transfected with mutant proviruses (Table 1), the effects of the point
mutations on the stability of cytoplasmic unspliced RNA were
investigated. To directly ascertain the effects of the dr1 mutations on
RNA stability, QT6 cells were transfected with the mutant and wild-type constructs. Cells were treated with 2 µg of actinomycin D per ml
starting 40 h posttransfection. Cytoplasmic RNA was isolated at
various times and subjected to analysis by RNase protection assay (Fig.
5A). Unspliced cytoplasmic RNA from cells
transfected with mutant DNAs decayed with kinetics not significantly
different from the wild type (Fig. 5B). The spliced RNA's also decayed
similarly in all transfections (Fig. 5B). This result suggests that the six mutations did not decrease the stability of the unspliced message
and that there must be an alternative explanation for the disappearance
of unspliced RNA from the cytoplasm. As an additional control, the
stability of myc RNA was measured and found to be similar to
the stability of spliced env RNA (data not shown). One
possible explanation for the similar stability kinetics of the
wild-type and mutant unspliced RNAs is that the wild-type unspliced RNA
may actually be more stable than that of the mutant but is removed from
the cytoplasm more rapidly through more efficient packaging. Evidence
for this explanation is discussed below.


View larger version (45K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of dr1 mutations on cytoplasmic RNA stability.
QT6 cells transfected with the indicated mutant DNAs were treated with
2 µg of actinomycin D per ml at 40 h posttransfection for the
indicated times, when cytoplasmic RNA was harvested and subjected to
analysis by RNase protection as described above. (A) Representative
RNase protection assay performed as described above. (B) Amounts of
unspliced viral RNAs remaining at 6, 12, and 24 h as a fraction of
that amount present at the time of actinomycin D addition. Error bars
indicate the standard deviations computed from three separate
experiments.
|
|
ASLV dr1 mutants express amounts of Pr76 Gag protein similar to
those of wild-type ASLV.
Consistent with the effect on unspliced
cytoplasmic RNA, it has previously been shown that deletion of dr1 from
RSV proviral constructs results in low (22) or undetectable
(17) expression of Pr76 Gag protein in transfected cells.
Additionally, point mutations in the downstream dr1 result in reduced
expression of viral proteins in transfected cells (16).
To ascertain the efficiency of translation of unspliced viral RNA
containing the mutations described in the present study, the levels of
Gag in transfected cells were determined. Concentrated cell lysates
were subjected to SDS-PAGE and transferred to nitrocellulose membranes.
Gag was detected with anti RSV CA-NC antiserum (Fig. 6). No significant difference in Gag
expression was observed among the lysates of cells transfected with
mutant and wild-type DNA, in direct contrast to a previous report on
Gag expression in dr1 point mutants (16). Therefore, the
reduction in replication observed by the RT assay must be due to a
defect in a replication step that occurs after the translation of Gag.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of dr1 mutations on Pr76 Gag expression. Total
cellular protein was isolated from QT6 cells transfected with the
indicated mutant DNAs isolated at 40 h posttransfection. Then, 30 µg of protein was loaded per lane and subjected to SDS-PAGE and
Western transfer. Pr76 Gag was detected with rabbit antiserum reactive
to p27 CA and p7 NC. An alkaline phosphatase-conjugated secondary
antibody was used in conjunction with a fluorescent substrate to detect
the bands.
|
|
ASLV dr1 point mutants package genomic RNA approximately 10-fold
less efficiently than wild-type ASLV.
We therefore tested the
ability of the six dr1 point mutations to package unspliced RNA into
virions. Cell culture medium from transfected QT6 cells was filtered
and split into two equal samples, and the virus was pelleted. One
sample was directly resuspended in SDS-PAGE loading buffer for an
analysis of the virion proteins, and the other half was subjected to
RNA extraction. Both cytoplasmic RNA and viral RNA were analyzed by
RNase protection (Fig. 7A). The wild-type
DNA yielded about 10-fold more packaged viral RNA per unit amount of
RNA in the cell cytoplasm than did any one of the six mutants (Fig.
7B). Since the difference in packaging could be due to fewer particles
produced rather than the production of "empty" particles, viral
genomic RNA was compared to virion-associated p27 CA protein (Fig.
8A). The wild-type DNA yielded about
10-fold more packaged viral RNA per unit amount of p27 CA protein than did any one of the six mutants (Fig. 8B). The result of this experiment strongly suggests that the reduction in packaging is due to the production of particles that are approximately 90% reduced in genomic
viral RNA compared to the wild type rather than to a reduction in
particle production.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of dr1 mutations on the packaging of genomic RNA.
Cytoplasmic RNA was harvested at 40 h posttransfection of QT6
cells, and virions were pelleted from the culture medium at 40 h
posttransfection by ultracentrifugation; RNA was then isolated. The
RNAs were subjected to analysis by RNase protection. (A) Representative
RNase protection assays showing viral RNA levels in virions and the
cytoplasm of transfected QT6 cells. (B) Ratios of virion unspliced-RNA
levels to cytoplasmic RNA levels calculated from the experiments shown
in panel A. Error bars indicate the standard deviations computed from
five separate transfections with the same DNA.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 8.
Effect of dr1 mutations on the production of virions.
Virions were pelleted from the culture medium of QT6 cells at 40 h
posttransfection with the indicated DNAs. Pelleted virions were used
for the preparation of RNA and were also subjected to SDS-PAGE and
Western blotting, followed by detection of p27 CA with p27-specific
antiserum. (A) Representative RNase protection assay and representative
Western blot. (B) Ratios of virion genomic RNA to virion p27 CA protein
calculated from the experiments shown in panel A. Error bars indicate
the standard deviations computed from five separate experiments.
|
|
To determine whether the packaging defect was a result of a
cis defect in the RNA or a trans defect in viral
proteins, QT6/BD cells were transfected with a wild-type proviral
construct expressing a subgroup B/E envelope and passaged twice to
allow virus spread and infection of most cells. The cells were then
transfected with mutant and wild-type viral constructs expressing the
subgroup B envelope. This protocol resulted in a competition between
the subgroup B-env-containing and the subgroup
B/E-env-containing genomes for packaging. RNA was extracted
from cells and virus and subjected to RNase protection by using two
probes, a subgroup B env probe that spanned the region of
gp85 where the two env genes differ most in sequence
(7, 8) and the splice donor spanning probe (Fig. 1). Virus
was also subjected to SDS-PAGE, Western transfer, and immunodetection
with anti-p27 CA antiserum. The wild-type subgroup B/E genomic RNA was
packaged, as was the wild-type subgroup B genomic RNA (Fig.
9A). However, the mutant subgroup B
genomic RNA could not compete with the wild-type subgroup B/E genomic
RNA and was therefore undetectable in virion RNA preparations (Fig.
9A). All virus preparations contained large amounts of packaged subgroup B/E genomic RNA, which resulted in two protected bands due to
inefficient cleavage by RNases at a base mismatch between probe and
subgroup B/E genomic RNA (Fig. 9A). p27 CA protein expression was
similar in all samples (Fig. 9B). Since the defect in packaging closely
resembled the reduction in replication (Fig. 3), we concluded that it
was the largest contributing factor to the replication defect.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 9.
Effect of the mutations on competition for packaging of
genomic RNA. QT6 cells were transfected with 10 µg of the wild-type
DNA encoding the subgroup B/E env and then passaged twice.
Cells were next transfected with 10 µg of the indicated DNAs encoding
the subgroup B env. (A) RNA was harvested at 40 h
posttransfection, and virions were pelleted from the culture medium;
RNA and protein were then isolated. The RNAs were subjected to analysis
by RNase protection with the two riboprobes described in Fig. 1. (B)
Virions were subjected to SDS-PAGE and Western blotting, followed by
detection of p27 CA with p27-specific antiserum.
|
|
 |
DISCUSSION |
The 3' UTR is well conserved among avian retroviruses and is
essential for efficient replication. However, a clear and uncontested role has not yet been ascribed to it. The dr1 element within the UTR
has been shown to have a significant role in the cytoplasmic accumulation of unspliced RNA (16, 17). Another report has shown the dr1 to play a role in genomic RNA packaging (24). Still another report has concluded that the dr1 has multiple roles and
that particle production is profoundly reduced when both of the dr1s
are precisely deleted from an RSV construct containing src
(22). The difference in results may have resulted from the use of different strains of virus, slight differences among clones of
the same strain, or a variety of viral and nonviral polylinker sequences immediately flanking the different dr1 deletions and point
mutations used in the different studies. Even though Ogert et al.
(16) also utilized point mutations and obtained different results, their construct contained polylinker sequences flanking the
mutated dr1. The extra nonviral sequence may have been sufficient to
yield the different results. It should be noted, however, that cytoplasmic accumulation, as well as particle production, are necessary
for packaging. Therefore, packaging could not have been assessed
given the defect in cytoplasmic accumulation of unspliced RNA
(16, 17) or the defect in particle production
(22). In contrast to those studies, our constructs contained
only viral sequences since our cloning steps used natural restriction
sites found in the provirus, unlike some of the previous studies
(16, 17, 24).
The results presented here suggest that the dr1 element plays a
significant role in viral replication because it is necessary for the
efficient packaging of viral genomic RNA into virions. Proviral DNA
constructs bearing substitution mutations in this highly conserved
element were also found to have a measurable and reproducible reduction
in their accumulation of unspliced RNA in the cytoplasm. However, this
effect was too small to account for the reduction in replication
observed for all of the mutants. Also, the mutations did not directly
reduce the stability of their respective transcripts compared to the
wild type. Furthermore, expression of the Pr76 Gag precursor protein
was found to be unaffected by the mutations. The mutations did,
however, result in the production of viral particles that packaged
approximately 10-fold less genomic RNA per amount of cytoplasmic
unspliced RNA and per amount of virion p27 CA protein.
It has previously been reported that the dr1 element is necessary for
efficient replication of ASLV (16, 17, 22, 24). The
replication kinetics shown by the mutants described in this study
confirm those results by examining a limited number of replication cycles in DF1 cells (Fig. 3).
Previous work has shown that deleting dr1, as well as introducing a
different set of point mutations into dr1, results in decreased
cytoplasmic accumulation of unspliced viral RNA (16, 17).
Furthermore, dr1 was found to facilitate cytoplasmic accumulation of
heterologous unspliced RNA (17). However, its role as a CTE in its natural context, a role analogous to that of simian type D
retroviruses (3, 33), has been difficult to prove. Without measurable nuclear retention, it is difficult to conclude that, in the
context of an RSV genome, the 3' UTR functions as a true CTE. The point
mutations we characterized here did not greatly affect the cytoplasmic
accumulation of unspliced RNA, particularly compared to the same ratio
for the total cellular RNA sample (Table 1). We therefore conclude
that, if facilitating the cytoplasmic accumulation of unspliced RNA is
a critical function of the dr1, that function was not significantly
affected by our point mutations.
Recent studies examining steady-state levels of viral RNA in
transfected cells treated with actinomycin D have demonstrated that
deletion of dr1 results in a modest decrease in stability of the
unspliced transcript (17, 22). We conducted similar experiments with constructs containing dr1 point mutations and observed
no effect on the stability of unspliced cytoplasmic RNA. It should be
noted, however, that the previous stability studies examined total
cellular RNA, whereas we examined only the cytoplasmic fraction
(17, 22). Interpretation of this result may be complicated by the reduction in genomic RNA packaging caused by the mutants. It is
possible that the wild-type unspliced transcript is more stable than
that of any one mutant but that the more efficient packaging of the
wild-type genomic RNA leads to reduced cytoplasmic levels. This same
packaging difference could also explain the similar levels of Pr76 Gag
protein in cells expressing mutant and wild-type RNA (Fig. 6), despite
seemingly higher levels of wild-type unspliced RNA. Even though the
transfections with wild-type DNA produced higher steady-state levels of
cytoplasmic unspliced RNA (Fig. 4 and 5), a higher percentage of it was
encapsidated and therefore was untranslatable.
Defective packaging of the genomic RNA was the most pronounced
phenotype of the six mutants tested. In contrast to the results of
other investigators (16, 17, 22), the mutants presented here
produced Gag protein (Fig. 6) and particles as efficiently as did the
wild type (Fig. 8), demonstrating that no translation or assembly
defects had arisen as a result of introducing point mutations into the
dr1. The effect we observed is instead more in agreement with other
reports describing the negative effects of the dr1 deletion on
packaging (24) and infectious particle production
(22).
Although mutations in dr1 can strongly affect packaging, the element is
not absolutely required for this process. We (25) and others
(2) have found that spliced RNAs containing the virus 5' end
but heterologous sequences 3' of the splice site can be efficiently
incorporated into virions. Furthermore, it has been shown that an RCAS
vector containing the hygromycin gene packaged genomic RNA 10-fold less
efficiently when its dr1 was deleted (1). Therefore, the
role of dr1 in packaging seems to be limited to RNAs containing viral
3' sequences. These results suggest that dr1 interacts with adjacent
sequence, possibly forming a secondary or tertiary structure in
conjunction with more distal sequence, to promote packaging. If the
overall shape of the RNA is important for packaging, then either a
positive role for the intron or a negative role for the juxtaposition
of 5' and 3' sequences must also be considered, since env
RNA is packaged inefficiently relative to genomic RNA. The presence of
packaging determinants at both ends of spliced and unspliced avian
retrovirus RNAs strongly suggests that different overall RNA structures
are formed by both molecules. Packaging selectivity, therefore, may
result from the generation of only one efficiently packageable molecule.
We cannot conclude from this study whether the dr1 element is necessary
solely for efficient packaging or whether it serves other functions.
The mutations characterized herein clearly inhibit packaging through
the introduction of a cis defect in the genomic RNA, but
these mutations spanned only about one-half of the dr1 and included
only bases predicted to be unpaired in the putative secondary
structure. The regions of dr1 that remained unaltered by the 13 mutations may well encode other activities.
 |
ACKNOWLEDGMENTS |
We thank Volker Vogt, Karen Beemon, and Richard Katz for helpful
discussion and for providing reagents and David Lazinski, Naomi
Rosenberg, Linc Sonenshein, and Elliot Androphy for helpful discussion.
We thank G. Johah Rainey, Marcello Vinces, and Christopher Tipper for
their assistance and Mary Bostic-Fitzgerald for preparing the manuscript.
J.M.A. was supported by training grant 5T32GM07310 and by an
award from the National Cancer Institute R35CA44385 to J.M.C. J.M.C. is an American Cancer Society Research Professor.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Microbiology, Tufts University School of
Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-6750. Fax: (617) 636-0337. E-mail:
jcoffin_par{at}opal.tufts.edu.
Present address: Department of Animal Science, University of
Minnesota, St. Paul, MN 55108.
 |
REFERENCES |
| 1.
|
Aronoff, R., and M. L. Linial.
1991.
Specificity of retroviral RNA packaging.
J. Virol.
65:71-80[Abstract/Free Full Text].
|
| 2.
|
Banks, J. D.,
A. Yeo,
K. Green,
F. Cepeda, and M. L. Linial.
1998.
A minimal avian retroviral packaging sequence has a complex structure.
J. Virol.
72:6190-6194[Abstract/Free Full Text].
|
| 3.
|
Bray, M.,
S. Prasad,
J. W. Dubay,
E. Hunter,
K.-T. Jeang,
D. Rekosh, and M.-L. Hammarskljold.
1994.
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.
Proc. Natl. Acad. Sci. USA
91:1256-1260[Abstract/Free Full Text].
|
| 4.
|
Cullen, B.
1994.
RNA-sequence-mediated gene regulation in HIV-1.
Infect. Agents Dis.
3:68-76[Medline].
|
| 5.
|
Cullen, B. R.
1991.
Regulation of HIV-1 gene expression.
FASEB J.
5:2361-2368[Abstract].
|
| 6.
|
Cullen, B. R.
1992.
Mechanism of action of regulatory proteins encoded by complex retroviruses.
Microbiol. Rev.
56:375-394[Abstract/Free Full Text].
|
| 7.
|
Dorner, A. J.,
J. P. Stoye, and J. M. Coffin.
1986.
Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85.
Cell
45:365-374[Medline].
|
| 8.
|
Dorner, A. J.,
J. P. Stoye, and J. M. Coffin.
1985.
Molecular basis of host range variation in avian retroviruses.
J. Virol.
53:32-39[Abstract/Free Full Text].
|
| 9.
|
Ernst, R. K.,
M. Bray,
D. Rekosh, and M. L. Hammarskjold.
1997.
Secondary structure and mutational analysis of the Mason-Pfizer monkey virus RNA constitutive transport element.
RNA
3:210-222[Abstract].
|
| 10.
|
Feinberg, M. B.,
R. F. Jarrett,
A. Aldovini,
R. C. Gallo, and F. Wong-Staal.
1986.
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
Cell
46:807-817[Medline].
|
| 11.
|
Fischer, U.,
S. Meyer,
M. Teufel,
C. Heckel,
R. Luhrmann, and G. Rautmann.
1994.
Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.
EMBO J.
13:4105-4112[Medline].
|
| 12.
|
Himly, M.,
D. Foster,
I. Bottoli,
J. Iacovoni, and P. Vogt.
1998.
The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses.
Virology
248:295-304[Medline].
|
| 13.
|
Katz, R. A.,
C. A. Omer,
J. H. Weis,
A. Mitsialis,
A. J. Faras, and R. V. Guntaka.
1982.
Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions.
J. Virol.
42:346-351[Abstract/Free Full Text].
|
| 14.
|
McNally, M. T.,
R. R. Gontarek, and K. Beemon.
1991.
Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.
Virology
185:99-108[Medline].
|
| 15.
|
Moscovici, C.,
M. G. Moscovici,
H. Jimenez,
M. M. C. Lai,
M. J. Hayman, and P. K. Vogt.
1977.
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.
Cell
11:95-103[Medline].
|
| 16.
|
Ogert, R. A., and K. L. Beemon.
1998.
Mutational analysis of the Rous sarcoma virus dr posttranscriptional control element.
J. Virol.
72:3407-3411[Abstract/Free Full Text].
|
| 17.
|
Ogert, R. A.,
L. H. Lee, and K. L. Beemon.
1996.
Avian retrovirus RNA element promotes unspliced RNA accumulation in the cytoplasm.
J. Virol.
70:3834-3843[Abstract].
|
| 18.
|
Olsen, H. S.,
S. Beidas,
P. Dillon,
C. A. Rosen, and A. W. Cochrane.
1991.
Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element.
J. Acquired Immune Defic. Syndr.
4:558-567.
|
| 19.
|
Olsen, H. S.,
A. W. Cochrane,
P. J. Dillon,
C. M. Nalin, and C. A. Rosen.
1990.
Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.
Genes Dev.
4:1357-1364[Abstract/Free Full Text].
|
| 20.
|
Richard, N.,
S. Iacampo, and A. Cochrane.
1994.
HIV-1 rev is capable of shuttling between the nucleus and cytoplasm.
Virology
204:123-131[Medline].
|
| 21.
|
Schwartz, D. E.,
R. Tizard, and W. Gilbert.
1983.
Nucleotide sequence of Rous sarcoma virus.
Cell
32:853-869[Medline].
|
| 22.
|
Simpson, S. B.,
L. Zhang,
R. C. Craven, and C. M. Stoltzfus.
1997.
Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle.
J. Virol.
71:9150-9156[Abstract].
|
| 23.
|
Sodroski, J.,
W. C. Goh,
C. Rosen,
A. Dayton,
E. Terwilliger, and W. Haseltine.
1986.
A second post-transcriptional trans-activator gene required for HTLV-III replication.
Nature
321:412-416[Medline].
|
| 24.
|
Sorge, J.,
W. Ricci, and S. H. Hughes.
1983.
cis-Acting packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.
J. Virol.
48:667-675[Abstract/Free Full Text].
|
| 25.
|
Swain, A., and J. M. Coffin.
1992.
Mechanism of transduction by retroviruses.
Science
255:841-845[Abstract/Free Full Text].
|
| 26.
|
Tabernero, C.,
A. S. Zolotukhin,
J. Bear,
R. Schneider,
G. Karsenty, and B. K. Felber.
1997.
Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1.
J. Virol.
71:95-101[Abstract].
|
| 27.
|
Tiley, L. S.,
M. H. Malin,
H. K. Tewary,
P. G. Stockley, and B. R. Cullen.
1992.
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 rev protein.
Proc. Natl. Acad. Sci. USA
89:758-762[Abstract/Free Full Text].
|
| 28.
|
Tsichlis, P. N., and J. M. Coffin.
1980.
Recombinants between endogenous and exogenous avian tumor viruses: role of the c region and other portions of the genome in the control of replication and transformation.
J. Virol.
33:238-249[Abstract/Free Full Text].
|
| 29.
|
Tsichlis, P. N.,
K. F. Conklin, and J. M. Coffin.
1980.
Mutant and recombinant avian retroviruses with extended host range.
Proc. Natl. Acad. Sci. USA
77:536-540[Abstract/Free Full Text].
|
| 30.
|
Van Beveren, C.,
J. M. Coffin, and S. Hughes.
1985.
Appendixes, p. 559-1222.
In
R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 31.
|
Weiss, R.,
N. Teich,
H. Varmus, and J. Coffin.
1982.
RNA tumor viruses.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 32.
|
Weiss, R.,
N. Teich,
H. Varmus, and J. Coffin.
1985.
RNA tumor viruses, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 33.
|
Zolotukhin, A. S.,
A. Valentin,
G. N. Pavlakis, and B. K. Felber.
1994.
Continuous propagation of RRE( ) and Rev( )RRE( ) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
J. Virol.
68:7944-7952[Abstract/Free Full Text].
|
| 34.
|
Zuker, M., and A. B. Jacobson.
1995.
"Well-determined" regions in RNA secondary structure prediction: analysis.
Nucleic Acids Res.
23:2791-2798[Abstract/Free Full Text].
|
Journal of Virology, September 1999, p. 7421-7429, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rainey, G. J. A., Coffin, J. M.
(2006). Evolution of Broad Host Range in Retroviruses Leads to Cell Death Mediated by Highly Cytopathic Variants. J. Virol.
80: 562-570
[Abstract]
[Full Text]
-
Roberts, T. M., Boris-Lawrie, K.
(2003). Primary Sequence and Secondary Structure Motifs in Spleen Necrosis Virus RU5 Confer Translational Utilization of Unspliced Human Immunodeficiency Virus Type 1 Reporter RNA. J. Virol.
77: 11973-11984
[Abstract]
[Full Text]
-
Rainey, G. J. A., Natonson, A., Maxfield, L. F., Coffin, J. M.
(2003). Mechanisms of Avian Retroviral Host Range Extension. J. Virol.
77: 6709-6719
[Abstract]
[Full Text]
-
Beasley, B. E., Hu, W.-S.
(2002). cis-Acting Elements Important for Retroviral RNA Packaging Specificity. J. Virol.
76: 4950-4960
[Abstract]
[Full Text]
-
Dangel, A. W., Hull, S., Roberts, T. M., Boris-Lawrie, K.
(2002). Nuclear Interactions Are Necessary for Translational Enhancement by Spleen Necrosis Virus RU5. J. Virol.
76: 3292-3300
[Abstract]
[Full Text]
-
Zhou, H., Rainey, G. J., Wong, S.-K., Coffin, J. M.
(2001). Substrate Sequence Selection by Retroviral Integrase. J. Virol.
75: 1359-1370
[Abstract]
[Full Text]
-
Paca, R. E., Ogert, R. A., Hibbert, C. S., Izaurralde, E., Beemon, K. L.
(2000). Rous Sarcoma Virus DR Posttranscriptional Elements Use a Novel RNA Export Pathway. J. Virol.
74: 9507-9514
[Abstract]
[Full Text]
-
Guo, W., Winistorfer, S. C., Stoltzfus, C. M.
(2000). Selective Inhibition of Splicing at the Avian Sarcoma Virus src 3' Splice Site by Direct-Repeat Posttranscriptional cis Elements. J. Virol.
74: 8513-8523
[Abstract]
[Full Text]
-
Bacharach, E., Gonsky, J., Lim, D., Goff, S. P.
(2000). Deletion of a Short, Untranslated Region Adjacent to the Polypurine Tract in Moloney Murine Leukemia Virus Leads to Formation of Aberrant 5' Plus-Strand DNA Ends In Vivo. J. Virol.
74: 4755-4764
[Abstract]
[Full Text]
-
Heinkelein, M., Thurow, J., Dressler, M., Imrich, H., Neumann-Haefelin, D., McClure, M. O., Rethwilm, A.
(2000). Complex Effects of Deletions in the 5' Untranslated Region of Primate Foamy Virus on Viral Gene Expression and RNA Packaging. J. Virol.
74: 3141-3148
[Abstract]
[Full Text]